Try our Advanced Search for more refined results
August 22, 2012
ViiV Healthcare Company et al v. Mylan Inc. et al
Case Number:
1:12-cv-01065
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 24, 2012
ViiV, Vertex Sue Over Mylan's Bid To Market Generic Lexiva
ViiV Healthcare Co. and Vertex Pharmaceuticals Inc. slapped Mylan Inc. with a patent infringement lawsuit in Delaware on Wednesday over Mylan's bid for U.S. regulatory approval to make and sell a generic version of the anti-HIV drug Lexiva.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login